AMCP 2024

Certara is a household name in model-informed drug development, but we also help biopharma companies establish and communicate product value through our Market Access & Pricing services. What’s unique about Certara Market Access? In addition to fundamental services like health economic modeling and dossier development, we are:

• Blending industry expertise with payer insights – our US Access Strategy team will be in New Orleans to share how our unique mix of industry expertise and payer community insights can answer even the most challenging market access and pricing questions.

• Expanding what’s possible in the realm of RWD and RWE – an ongoing partnership with Gilead to support the use of remdesivir recently earned a citation in NIH COVID-19 treatment guidelines, a rare achievement for RWD.
• Empowering stakeholders to communicate product value through technology – the BaseCase platform empowers Market Access, HEOR, and payer engagement teams to improve value communication with dynamic visuals and custom-built applications for tailored storytelling.

We’d welcome the opportunity to introduce you to Certara Market Access in New Orleans and explain how we can help you establish and communicate your product’s value through our consulting services and proprietary software platform, BaseCase.